睪固酮替代療法市場規模、佔有率、成長分析、按產品類型、按活性成分、按最終用戶、按地區 - 行業預測，2024-2031 年

睪固酮替代療法的全球市場規模預計到 2022 年約為 14 億美元，預測期內（2024-2031 年）複合年成長率為 8.9%，高於 2023 年的 15 億美元和 2031 年的 29 億美元。達到10億美元。

由於人口老化、生活方式改變和壓力水平上升等因素的綜合作用，導致睪固酮缺乏症增加，全球睪固酮替代療法（TRT）市場正在顯著成長。 TRT 涵蓋多種產品和治療方法，包括注射劑、凝膠劑、貼片和丸劑，以及對於準確診斷和管理低睪固酮水平至關重要的診斷測試和監測設備。睪固酮的產生自然會隨著老齡化的成長而下降，導致對有效治療方案的需求不斷成長，而人口老化是一個主要促進因素。此外，醫療保健專業人員透過診斷缺陷、制定適當的治療方案以及確保患者安全和治療有效性，在該市場中發揮關鍵作用。主導製藥公司和診所持續不斷的研究和開發工作，市場正在不斷發展，推出新的創新 TRT 解決方案。這種成長趨勢在美國市場尤其明顯，預計未來幾年將維持持續的年複合成長率（CAGR）。隨著對睾酮替代療法的需求持續上升，該市場的定位是改善睾酮缺乏症患者的生活品質，這表明其對更廣泛的製藥和醫療領域的重要性。總體而言，TRT 市場正變得越來越重要，因為它尋求滿足不斷變化的人口的醫療保健需求。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 監管分析
• 案例研究分析
• 專利分析
• 價格分析

睾酮替代療法市場：按產品類型

• 市場概況
• 注射
• 外用
• 其他

睪固酮替代療法市場：依活性成分分類

• 市場概況
• 十一烷酸睪酮
• 環丙酸睪酮
• 睪固酮
• 庚酸睪酮
• 其他

睾酮替代療法市場：按最終用戶分類

• 市場概況
• 醫院
• 診所

睾酮替代療法市場規模：按地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• AbbVie Inc.
• Pfizer Inc.
• Endo International plc
• Teva Pharmaceutical Industries Ltd.
• Bausch Health Companies Inc.
• Acerus Pharmaceuticals Corporation
• Marius Pharmaceuticals
• Insud Pharma SL
• Allergan
• Hikma Pharmaceuticals PLC
• Cipla Inc.
• Sun Pharmaceutical Industries Ltd.
• Lupin Pharmaceuticals
• Novartis AG
• AstraZeneca

Global Testosterone Replacement Therapy Market size was valued at around USD 1.4 billion in 2022 and is expected to rise from USD 1.5 billion in 2023 to reach a value of USD 2.9 billion by 2031, at a CAGR of 8.9% over the forecast period (2024-2031).

The Global Testosterone Replacement Therapy (TRT) market is experiencing significant growth, driven by a confluence of factors including an aging population, lifestyle changes, and an increase in stress levels, which have all contributed to rising testosterone deficiencies. TRT encompasses a range of products and treatment modalities such as injections, gels, patches, and pellets, alongside diagnostic tests and monitoring devices essential for accurate diagnosis and management of low testosterone levels. The aging demographic is a key driver, as testosterone production naturally declines with age, leading to a greater need for effective therapy options. Additionally, healthcare professionals play a crucial role in this market by diagnosing deficiencies, prescribing suitable treatments, and ensuring patient safety and treatment efficacy. With ongoing research and development efforts spearheaded by pharmaceutical companies and clinics, the market is evolving to introduce new and innovative TRT solutions. This growth trend is underscored in the US market, which is projected to maintain a sustainable compound annual growth rate (CAGR) in the upcoming years. As the demand for testosterone replacement therapy continues to rise, the market is positioned to enhance the quality of life for individuals experiencing deficiencies, marking its significance within the broader pharmaceutical and medical sectors. Overall, the TRT market is becoming increasingly vital as it seeks to address the healthcare needs of an evolving population.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Testosterone Replacement Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Testosterone Replacement Therapy Market Segmental Analysis

Global Testosterone Replacement Therapy Market is segmented by Product Type, Active ingredients, End User, and region. Based on Product Type, the market is segmented into Injectables, Topical, and Others. Based on Active ingredients, the market is segmented into Testosterone Undecanoate, Testosterone Cypionate, Testosterone, Testosterone Enanthate, and Others. Based on End User, the market is segmented into Hospitals, Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Testosterone Replacement Therapy Market

The growing prevalence of testosterone insufficiency, especially among males aged 40 to 79, is a significant market driver for the global testosterone replacement therapy (TRT) market. With approximately 20% of men over 60 and 30% over 70 experiencing low testosterone levels, combined with an estimated 10% to 40% of the global male population affected by this condition, the demand for effective TRT solutions is surging. Additionally, the upward trajectory of the elderly demographic further compounds this need, creating increased awareness and acceptance of TRT as a viable treatment option, thereby propelling market growth and innovation in therapeutic offerings.

Restraints in the Global Testosterone Replacement Therapy Market

The global testosterone replacement therapy market faces significant restraints due to the substantial risk of various post-treatment complications, including sleep apnea, acne, gynecomastia, and heightened risk of thromboembolic events. These potential side effects deter patients and healthcare providers from pursuing treatment, thereby inhibiting market growth. Additionally, the high costs associated with testosterone therapy, coupled with the need for ongoing medical supervision and potential follow-up treatments, further limits accessibility for patients. These combined factors contribute to hesitance among both consumers and practitioners, ultimately stifling the demand and expansion of the testosterone replacement therapy market on a global scale.

Market Trends of the Global Testosterone Replacement Therapy Market

The global testosterone replacement therapy (TRT) market is experiencing a notable shift towards personalized treatment options, catering to individual patient needs. This trend has spurred the growth of compounding pharmacies that offer customizable formulations. In tandem, pharmaceutical companies are innovating delivery methods, introducing products like nasal sprays and transdermal patches to enhance treatment convenience and efficacy. Additionally, an integrated approach combining TRT with lifestyle changes is gaining traction, advocating for holistic hormone management. The rise of digital health technologies further transforms the market, with telemedicine facilitating remote consultations, while mobile apps monitor hormone levels, ultimately improving patient access and engagement in their TRT journey.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Analysis
• Case Study Analysis
• Patent Analysis
• Pricing Analysis

Testosterone Replacement Therapy Market, By Product Type

• Market Overview
• Injectables
• Topical
• Others

Testosterone Replacement Therapy Market, By Active ingredients

• Market Overview
• Testosterone Undecanoate
• Testosterone Cypionate
• Testosterone
• Testosterone Enanthate
• Others

Testosterone Replacement Therapy Market, By End User

• Market Overview
• Hospital
• Clinics

Testosterone Replacement Therapy Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo International plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acerus Pharmaceuticals Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marius Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insud Pharma S.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments